Things to Know about Pramiracetam
Pramiracetam is synthetically gotten from piracetam, the first lab manufactured nootropic, only that it is more potent. Pramiracetam has been subjected to numerous extensive studies to discover its potential for treating memory loss and cognitive problems associated with Alzheimer’s disease and brain injury, and also as a way of treating different central nervous system disorders. It has been clinically proven to boost cognition in young adults suffering from memory problems as well as improving memory in healthy, elderly adults suffering from memory loss. Through anecdotal evidence, we know that Pramiracetam is effective in boosting productivity and focus as well as optimising overall brain function, making it a popular choice among people seeking to enhance their mental abilities such as the students. In the US, the USFDA has not approved Pramiracetam for any specific use, meaning it is unregulated and can be legally purchased and used.
Pramiracetam is a nootropic drug, made with the specific aim of enhancing cognition, with its beneficial effects including; boasted learning capacity, dementia treatment, enhanced social fluency and improved memory.
Over several decades, extensive testing on both animals and clinical trials on young adults suffering from cognitive impairment brought about by brain injuries, have revealed that Pramiracetam is very effective in enhancing memory. Upon taking Pramiracetam, memory gets improved by stimulating the hippocampus, the section of the brain responsible for creating new memories and reducing forgetfulness by acting as an effective anti-amnesic. The dual effectiveness makes Pramiracetam a good memory booster, with most users reporting tremendous improvement in speed of recall, a claim that can be backed by animal studies.
Pramiracetam has become quite popular among students that seek a reliable study aid due to its overall cognitive enhancing effects that increase alertness and expand learning capacity. Animal studies suggest that Pramiracetam takes part in the mechanisms underlying memory improvement and learning by improving neuronal type activity in the hippocampus.
Trials conducted on individuals with primary degenerative dementia reveal that Pramiracetam reversed amnesia, consequently reducing forgetfulness and enhancing recall. Significant improvements in memory and cognition were achieved in patients with mild-moderation dementia in a study seeking to measure the effects of racetam nootropics including Pramiracetam. The results can be explained in part by the nootropic’s ability to enhance existing neurotransmitters. While not approved as a treatment for Alzheimer’s disease in the US, Pramiracetam often gets prescribed in Europe as a treatment for dementia, cognitive issues associated with Alzheimer’s disease as well as other neurological disorders.
While no documented research exists, Pramiracetam has been reported by most users to improve their social fluency and conversational creativity.